https://www.pharmamanufacturing.com/industry-news/news/55394947/asymchems-carbapenem-api-facility-passes-first-fda-pre-approval-inspectionPharma Manufacturingen2026-07-31T16:43:05.000ZAsymchem’s carbapenem API facility passes FDA pre-approval inspectionhttps://www.pharmamanufacturing.com/industry-news/news/55394945/hilleman-laboratories-secures-up-to-85m-for-ebola-vaccine-manufacturingPharma Manufacturingen2026-07-31T16:42:25.000ZHilleman Laboratories secures up to $8.5M for ebola vaccine manufacturinghttps://www.pharmamanufacturing.com/industry-news/news/55394621/lilly-resilience-expand-manufacturing-partnership-with-750m-ohio-investmentPharma Manufacturingen2026-07-30T13:57:05.000ZLilly, Resilience partner with $750M Ohio investmenthttps://www.pharmamanufacturing.com/industry-news/news/55394588/octapharma-to-build-15b-us-plasma-manufacturing-facilityPharma Manufacturingen2026-07-30T12:19:10.000ZOctapharma to build $1.5B US plasma manufacturing facilityhttps://www.pharmamanufacturing.com/industry-news/news/55394587/cellipont-reaches-100th-gmp-batch-milestone-one-year-after-launchPharma Manufacturingen2026-07-30T11:54:53.000ZCellipont reaches 100th GMP batch one year after launch